Pharmaceutical manufacturers of Paracetamol

Granules India Limited is a rapidly expanding pharmaceutical company with top-notch amenities for APIs, PFIs and Finished Dosages, catering to clients in more than 60 nations. We are dedicated to upholding high standards in production, excellence and client relations. Our main office is situated in Hyderabad, and we also have branches in the United States, United Kingdom, Colombia and China, as well as production facilities in India and China.

With more than six decades of experience as a leading supplier of materials to the pharmaceutical sector, we comprehend the requirements necessary to support our clients' achievements. Solvay possesses a diverse range of specialty polymers that empower pharmaceutical firms to create novel and improved applications, ultimately ensuring safer and more effective outcomes for patients worldwide

Recipharm is an experienced, global CDMO dedicated to meeting your evolving needs through operational excellence, scientific know-how and customer connectivity. Our worldwide reach, localised market knowledge and ever-expanding alliance of expertise allow us to anticipate your needs and provide tailored, reliable services to consistently deliver on time and in full.

MNK’s Specialty Generics division provides a wide variety of high-quality generic medications, focusing on pain relief, addiction treatment, and ADHD, as well as a comprehensive range of active pharmaceutical ingredients (APIs), such as acetaminophen/paracetamol, DEA scheduled compounds, and stearates. We run the largest API facility in the United States. Discover the range of excipients available from Mallinckrodt Pharmaceuticals for use in pharmaceutical drug delivery systems (DDS).

We, at TIEFENBACHER GROUP, are driven by a deep sense of purpose: we are pioneering healthcare to improve patients’ lives around the world. We believe that the access to affordable high quality-healthcare is a human right. We always challenge the status quo to be one step ahead – in terms of business models as well as concrete products and services. This entrepreneurial spirit is the driving force of making high-quality pharmaceuticals more affordable, more available, and better than before. 100% family owned since 1963, we are a purpose-driven healthcare company providing best-in-class solutions throughout the entire pharmaceutical value chain. From initial idea to market access: We distribute raw materials and develop, manufacture, and register finished dosage forms like tablets, capsules, powders, drops, and patches as well as medical devices. This broad competence enables us to pioneer healthcare holistically as we can connect ideas and expertise to create novel healthcare solutions. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-functional structures, we tap into our full potential and stay at the forefront of our field.

CCSB has developed more than 30 bulk pharmaceutical products including Anti-Anxiety agent, Antidiabetics, Laxatives, Antifungals, Antihistamines, Antiseptics, Antiulcerants, Cardiovascular drugs, Skeletal, Muscle relaxants, Hypolipaemics, Antineoplastic, Antihyperlipedemia and Immunosuppresant. In 1984, CCSB was the first pharmaceutical manufacturer in Taiwan inspected and approved by FDA for cGMP compliance. CCSB has filed DMF's for 19 products with the FDA.

Sri Krishna Pharmaceuticals Ltd (SKPL), established in 1974, started life as a pioneer in the bulk manufacture of acetaminophen (Paracetamol) for the domestic Indian market. Today, the company is a vertically integrated bulk manufacturer of multiple first-line-of-defence APIs, PFIs and finished dosage drugs. Paracetamol is still very important to the company and the company remains one of the largest manufacturers in the world. The role of Indian bulk drug manufacturers in the global pharma supply chain has evolved greatly, with SKPL increasing its presence in the synthesis of bulk APIs, direct compression, intermediate and finished dosage products.

To help you reach your next business goal, we live our values in everything we do, provide premium service at every step, and always put people first. Putting people first at every step, IOL Chemicals and Pharmaceuticals Limited is a purpose and service-driven Active Pharma Ingredients (API) Products, Intermediates and Specialty Chemicals Company. Driven by principles of excellence, successful innovation and global leadership, IOL Chemicals and Pharmaceuticals Limited is one of the best pharmaceuticals and specialty chemical companies across the globe built on a prolific history of progress and expansion over three decades. Built on a strong foundation of trust, reliability, vision, and partnership, we galvanize our workers into thinking bigger and aiming higher. Our expanding product portfolio will provide a hands-on, realistic solution to today’s healthcare problems. Today, IOL Chemicals and Pharmaceuticals Limited as emerged as the best pharma API manufacturing company because we invest in people, experience and passion.

Adare Pharma Solutions is a global technology-driven CDMO providing product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical industry. Adare’s specialized technology platforms provide taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions. With a proven history in drug delivery, Adare has developed and manufactured more than 65 products sold by customers in more than 100 countries globally.

Established in 1997, Temad Co. has been operating for over two decades and is recognized as one of the leading manufacturers of APIs in Iran. It is also known for its groundbreaking production of both narcotic and non-narcotic products with exceptional quality within the Middle East. In addition to adhering to Iranian GMP regulations, Temad has met the national and international standards of API manufacturing, including ISO 9001/14001/17025/45001 and OHSAS 18001. With a portfolio of over 115 pharmaceutical products, Temad ensures compliance with GMP and WHO standards as well as regulations for both narcotic and non-narcotic medications. The company proudly exports its diverse range of products to 45 countries across the globe.

ATABAY is an international company that specializes in producing generic branded medications and active pharmaceutical ingredients (API) with an annual capacity exceeding 200 million units and 6000 tons of API. Atabay's product range encompasses paracetamol and combinations, antivirals, various types of antibiotics, anticoagulants, and analgesics, as well as the fill/finish of other sterile liquid and lyophilized products aimed at enhancing human health. Atabay is dedicated to developing high-quality Paracetamol powder and DC grades at an FDA/USA and EU approved, backward integrated cGMP site.

Here at Yamamoto Corporation, we take immense pride in our dedication to creating original concepts using innovative technologies and implementing these ideas into profitable and marketable products that offer tangible advantages to society. Our primary range of cutting-edge, high-efficiency, rubber-based materials is utilized in various sectors including professional sports, healthcare, aerospace, apparel, and numerous other industries. We are dedicated to leveraging these products to advance our goal of enhancing the lives of our clients by providing convenience, wellness, safety, and comfort.

SpecGx manufactures a portfolio of generic pharmaceutical products, including certain opioid products for pain management. SpecGX is a subsidiary of Mallinckrodt Pharmaceuticals based in Saint Louis, MO.

The Meghmani LLP facility specializes in the production of Paracetamol/Acetaminophen Powder and is backward-integrated for Hydrogen, Caustic-Lye, and HCL. It produces PAP for captive consumption and holds CEP certification (CEP 2015-377), as well as approvals from MCC, WHO-GMP, WCC, ISO-14001, and OHSAS-18001. The facility has filed for USDMF (DMF No:02798) and can provide the open part of USDMF & EDMF for Dossier/ANDA filing. Audits from EuGMP, USFDA, KFDA, and COFEPRIS are expected in 2018, with exports to Asia, Middle-East, Latin-America, Central-America, and Africa markets already underway. In addition, the facility has a significant customer base in India and other major regions.

Anqiu Lu'an Pharmaceutical Co., Ltd. ( Former: Weifang No.4 Pharmaceutical Factory ) is the largest Asian bulk pharmaceutical enterprises specializing in producing and exporting Paracetamol (Acetaminophen) (annual capacity is 40,000 tons), Paracetamol DC (DC90, DC96, DC85, DC83, DC77 etc)(annual capacity is 7000 tons ),Paracetamol DC by spray drying(Capacity is 5000tons) and contract manufacture of Paracetamol Finish Dosage with annual capacity 8 billion tabs). Many thanks for encourage and supports of oversea partners, we implemented our procedures enabling our staffs and system to comply with c GMP practice. We organize production according to c GMP and our product quality is assured through controlled environments, micronizing operations strictly according to SOPs, validated process, trace ability throughout and best technology. Strict quality control assures the products released are of excellent quality. Paracetamol is covered by Certificate of Suitability and it’s facilities passed EDQM Site Inspection. Paracetamol DC is covered by EU GMP Certificate and it's facilities passed Germany Government of Upper Bavaria Site Inspection and US FDA Inspection. Paracetamol Finish Dosage is covered by Canada GMP Certificate and it's facilities passed Health Canada's Site Inspection and Malta authorities site inspection. Our company passes EHS site inspection made by global pharmaceutical giants. Around 80% of above products are exported to worldwide markets and currently most of multinational pharmaceutical companies worldwide are reliable and regularly supplied and served by us!

Farmson has been a trailblazer in the production of Paracetamol / Acetaminophen since its establishment in 1969. As the largest manufacturer of Paracetamol, we have a capacity of 45000 MT / Year. Additionally, we are the sole company with backward integration for intermediate Para Amino Phenol (PAP) and hold all major accreditations. Our presence spans across over 50 countries globally. Furthermore, we also possess the Direct Compression (DC) grade of Paracetamol with a world-class facility.

The Indukern Group operates from its main office, Indukern SA, and Kern Pharma in Barcelona, along with Indukern AG in Switzerland. It has established itself as a prominent producer and supplier of Active Pharmaceutical Ingredients and Substances, Fine Chemicals, Intermediates, and Excipients, as well as Veterinary Pharmaceuticals, along with Feed and Food Additives